Clinical trials
Phase 2 Biliary Tract Neoplasms trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| National Health Research Institutes, Taiwan | 3 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hoffmann-La Roche | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Cheng-Kung University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 13 |
| Cholangiocarcinoma | 3 |
| Colorectal Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.